The phrase "a combination of structure" is correct and usable in written English.
It can be used when discussing elements that are brought together to form a cohesive whole, particularly in contexts like architecture, design, or organizational frameworks.
Example: "The project is based on a combination of structure and creativity, ensuring both functionality and aesthetic appeal."
Alternatives: "a blend of structure" or "a mixture of structure".
For a sport like basketball, you really need a combination of structure and freedom.
In order to make a discriminative model that classifies group of SULT1A1 binders into substrates and inhibitors, a combination of structure, ligand-based, and docking based pharmacophores have been generated and validated by Ligandscout [4].
Novel small molecule inhibitors of heat shock protein 90 (Hsp90) were discovered with the help of a fragment based drug discovery approach (FBDD) and subsequent optimization with a combination of structure guided design, parallel synthesis and application of medicinal chemistry principles.
In the course of our research program to discover novel inhibitors of this trypanosomatid enzyme, we have explored a combination of structure and ligand-based virtual screening techniques as a complementary approach to a biochemical screening of natural products using a standard biochemical assay.
Quality of care can be defined as a combination of structure, process, and outcome [ 4].
In most P4P schemes, financial incentives were granted on the basis of performance on a combination of structure (n = 6) and/or process indicators (n = 6).
Starting from a virtual screening hit, activity was optimized through a combination of structure-based design and physical property optimization.
This unwanted property was successfully removed from the described inhibitors through a combination of structure-based design and medicinal chemistry activities.
Here we report on the identification of novel allosteric inhibitors of HCV NS5B through a combination of structure-based virtual screening and in vitro NS5B inhibition assays.
Graphical Abstract Using a combination of structure-based and ligand-based pharmacophores, agonist and antagonist ligands of the Nuclear Receptors included in the NRLiSt BDB database could be separated.
Here, we investigated the dynamics of the type I interferon (IFN) receptor, IFNAR1, and its effect on signaling upon binding IFN and IFNAR2 using a combination of structure-based mechanistic studies, in situ binding, and gene induction assays.
